search
Back to results

Open-label Trial Evaluating Four Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste, and Mouthwash

Primary Purpose

Oral Hygiene, Toothbrushing, Dental Plaque

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
the toothpaste is used with a standard toothbrush without any claims 3 times a day after the main meals for 28 days.
the mint toothpaste and mouthwash are used with the scalar toothbrush 33 medium with antibacterial " Spazzolino tau-marin®" 3 times a day after the main meals for 28 days.
subjects of this group will use their routine oral hygiene products.
Sponsored by
Biokosmes Srl
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Oral Hygiene focused on measuring Gingival sensitivity, manual toothbrush, mouthwash, oral hygiene, oral microbiota stability, oral mucosa, plaque reduction, toothbrush, toothpaste

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Healthy Caucasian males and females aged ≥ 18 to ≤ 65 years included. Proper oral hygiene not performed verified with Simplified Oral Hygiene Index (OHI-S) (score ≥ 2) and a questionnaire on oral habit. Patients able to comply with the requirements for the study and freely willing to provide written informed consent to the collection of their data. Registered with Italian National Health Service (NHS). Ability to understand the language used in the investigation center and to comply with the study procedures. Unbanned pharmacological therapy stable for at least one month without any changes during the study. Commitment not to change the daily routine and lifestyle. Exclusion Criteria: Allergies or sensitivity to oral care products, cosmetic products, drugs, patch or medical devices. Any oral cavity condition inappropriate for participation. Gums bleeding due to pathologies/pharmacological treatment. Concomitant or during the last week antibiotic therapy. Smokers (≥5 cigarettes/day). Acute, chronic or progressive diseases/illness/conditions able to interfere with the outcome of the study or considered dangerous or incompatible with the study requirements. Pathological staining of teeth. Breast-feeding, pregnancy, or women of child-bearing age unwilling to take the necessary precautions to avoid pregnancy during the study. Planning to participate or participation in other clinical trials withing 30 days. Hospitalization/planned hospitalization in a health or social facility. Deprivation of freedom by administrative or legal decision or under guardianship Inability to be contacted in case of emergency.

Sites / Locations

  • Studio D. Cattaneo
  • Complife Italia Srl

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Other

Other

Other

Other

Other

Arm Label

Group 1 (20 subjects)

Group 2 (12 subjects)

Group 3 (20 subjects)

Group 4 (20 subjects)

Group 5 (12 subjects)

Arm Description

using the delicate mint toothpaste "Dentifricio gel tau-marin® Menta Delicata".

using of the mint toothpaste "Dentifricio gel tau-marin® Menta".

using the mint mouthwash "Collutorio tau-marin® Menta.

using the delicate mint toothpaste "Dentifricio gel tau-marin® Menta Delicata", mint mouthwash "Collutorio tau-marin® Menta".

continuing to use their routine oral hygiene products.

Outcomes

Primary Outcome Measures

Gums sensitivity
Change from baseline to day 14 and 28 days assessed by the Investigator during the dentist examination using a 10 cm visual analogue scale (VAS) where 0 is absence of sensitivity and 10 indicates the maximum of sensitivity.
Rate of gingival irritations
Change from baseline to 14 and 28 days assessed by the Investigator during the dentist examination as follows: (Yes presence of gingival irritation; No = absence of gingival irritation).
Rate of oral mucosa lesions
Change from baseline to 14 and 28 days assessed by the Investigator during the dentist examination as follows: (Yes presence of oral mucosa lesion; No = absence of oral mucosa lesion).
Dental plaque assessment
Change from T0 (at the baseline at visit, performed three hours after the last teeth brushing) to Timm (evaluation done immediately after the first product use). The evaluation is carried out by means of an erythrosine-based disclosing tablet, which allows to quantify the presence of plaque on the teeth. First, the dentist gives the tablet to the subjects, who are asked to chew it thoroughly in their mouths. Then, the subjects are asked to rub the chewed particles of the tablets on their teeth with their tongue and swish the accumulated saliva in their mouth for about 60 seconds before rinsing with water. The releasing tablet stains the plaque on the teeth.
Teeth colour assessment
Change from baseline to 14 and 28 days as assessed by the investigator during the dentist's examination comparing the subjects' teeth with those shown on the VITAPAN® Score. The scoring system consists of a series of 16 "artificial teeth" in 16 different colors, each of which is associated with an alphanumeric code representing the entire chromatic space of natural teeth. It classifies tooth color into 4 families of shades as follows: reddish-brownish (A1, A2, A3, A3.5, A4), reddish-yellowish (B1, B2, B3, B4), grayish (C1, C2, C3, C4) and reddish-grey (D2, D3, D4).

Secondary Outcome Measures

Self-assessment questionnaire
Subjects are asked to complete a self-report questionnaire on Timm (immediately after first use) and on days 14 and 28.
Oral microbiota analysis
It evaluates the change from baseline to 28 days. Oral microbiota is obtained by brushing a defined area of the mouth. Swabs are collected and stored at room temperature. Microbiome analysis is based on metagenomic analysis of the 16S rRNA gene. The second step in the analysis pipeline is to isolate the bacterial DNA from other components of the sample. Through a series of cell lysis and extraction steps, the purified bacterial material is obtained. The bacterial material is then amplified by PCR, first to increase the amount of DNA, and second to label the genetic material - which will later allow identification of each sample during the sequencing step. The concentrations of the samples are equalized prior to pooling to create the sequencing mix. This solution is then loaded into a cartridge and analyzed by a sequencer. The biodiversity index (Shannon index) and statistics are calculated using a dedicated software (Microbiome analyst)
Serious Adverse Events/Adverse Events
The number of participants with treatment-related adverse events will be assessed by CTCAE v6.0

Full Information

First Posted
July 20, 2023
Last Updated
August 18, 2023
Sponsor
Biokosmes Srl
Collaborators
Opera CRO, a TIGERMED Group Company
search

1. Study Identification

Unique Protocol Identification Number
NCT05999175
Brief Title
Open-label Trial Evaluating Four Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste, and Mouthwash
Official Title
Evaluation of the Tolerability, Safety of Use, and Efficacy of Cosmetic Products for the Oral Care. In Use Test Under Dentist Control
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
May 17, 2022 (Actual)
Primary Completion Date
July 26, 2022 (Actual)
Study Completion Date
September 9, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Biokosmes Srl
Collaborators
Opera CRO, a TIGERMED Group Company

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this open-label, randomized controlled clinical trial, is to provide preliminary clinical data (efficacy on plaque and gingival sensitivity, and safety and tolerability of two types of toothpaste, a mouthwash, and a specifically custom-designed toothbrush used for 28 days), as well as descriptive data on the effects of the products on oral microbiota rebalancing and patient acceptability. Eighty-four participants with a history of poor oral hygiene are visited at baseline and after 28 days of administration of the tested products. The control group consisted of 12 participants who continued to use their oral care products without changing their normal routine. At baseline and at the end of treatment (final visit), the oral microbiome is also evaluated in a group of 12 subjects allocated randomly.
Detailed Description
A complete line of cosmetic products (Tau-marin Protezione e Prevenzione) was launched on the Italian market in 2023. These products are based on an innovative formulation containing a prebiotic (Bioecolia®) and a paraprobiotic based on Lactobacillus plantarum (SymrebootTM OC). The products are the toothpastes "Dentifricio Menta Delicata" and "Dentifricio Menta" and the mouthwash "Collutorio Menta". The products should preferably be used with the "Spazzolino tau-marin" toothbrush, which, thanks to the silver ions placed on the bristles, handle and head of the toothbrush, can eliminate Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa and Escherichia coli bacteria. Bioecolia® is an alpha-glucan oligosaccharide that is a preferred substrate for commensal bacteria and selectively stimulates their growth. SymrebootTM OC belongs to the class of paraprobiotics, i.e. non-viable microbial cells (either intact or disrupted) or crude cell extracts, which, when administered in adequate amounts, provide a health benefit to the user. SymrebootTM OC consists of heat treated Lactobacillus plantarum HEAL19. The combined action of prebiotic and paraprobiotic results in the restoration of the symbiosis. Stability and preclinical tests confirm the safety of these products for oral hygiene.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oral Hygiene, Toothbrushing, Dental Plaque
Keywords
Gingival sensitivity, manual toothbrush, mouthwash, oral hygiene, oral microbiota stability, oral mucosa, plaque reduction, toothbrush, toothpaste

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Study participants would be randomly allocated to one of the following groups: Group 1 (20 subjects) would use the delicate mint toothpaste "Dentifricio gel tau-marin® Menta Delicata"; Group 2 (12 subjects) mint toothpaste " Dentifricio gel tau-marin® Menta"; Group 3 (20 subjects) mint mouthwash "Collutorio tau-marin® Menta". Group 4 (20 subjects) would utilize delicate mint toothpaste "Dentifricio gel tau-marin® Menta Delicata" and mint mouthwash " Collutorio tau-marin® Menta". These products would be applied with tau-marin® scalar toothbrush 33 medium with antibacterial "Spazzolino tau-marin®" three times a day after the main meals for 28 days. Group 5 (12 subjects) would continue to use routine oral hygiene products for 28 days. Groups 1 to 3 would be provided with a standard toothbrush (without any claims of efficacy) to be used three times a day after the main meals for 28 days.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
84 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group 1 (20 subjects)
Arm Type
Other
Arm Description
using the delicate mint toothpaste "Dentifricio gel tau-marin® Menta Delicata".
Arm Title
Group 2 (12 subjects)
Arm Type
Other
Arm Description
using of the mint toothpaste "Dentifricio gel tau-marin® Menta".
Arm Title
Group 3 (20 subjects)
Arm Type
Other
Arm Description
using the mint mouthwash "Collutorio tau-marin® Menta.
Arm Title
Group 4 (20 subjects)
Arm Type
Other
Arm Description
using the delicate mint toothpaste "Dentifricio gel tau-marin® Menta Delicata", mint mouthwash "Collutorio tau-marin® Menta".
Arm Title
Group 5 (12 subjects)
Arm Type
Other
Arm Description
continuing to use their routine oral hygiene products.
Intervention Type
Device
Intervention Name(s)
the toothpaste is used with a standard toothbrush without any claims 3 times a day after the main meals for 28 days.
Intervention Description
the toothpaste is used with a standard toothbrush without any claims 3 times a day after the main meals for 28 days.
Intervention Type
Device
Intervention Name(s)
the mint toothpaste and mouthwash are used with the scalar toothbrush 33 medium with antibacterial " Spazzolino tau-marin®" 3 times a day after the main meals for 28 days.
Intervention Description
the mint toothpaste and mouthwash are used with the scalar toothbrush 33 medium with antibacterial " Spazzolino tau-marin®" 3 times a day after the main meals for 28 days.
Intervention Type
Device
Intervention Name(s)
subjects of this group will use their routine oral hygiene products.
Intervention Description
subjects of this group will use their routine oral hygiene products.
Primary Outcome Measure Information:
Title
Gums sensitivity
Description
Change from baseline to day 14 and 28 days assessed by the Investigator during the dentist examination using a 10 cm visual analogue scale (VAS) where 0 is absence of sensitivity and 10 indicates the maximum of sensitivity.
Time Frame
28 days
Title
Rate of gingival irritations
Description
Change from baseline to 14 and 28 days assessed by the Investigator during the dentist examination as follows: (Yes presence of gingival irritation; No = absence of gingival irritation).
Time Frame
28 days
Title
Rate of oral mucosa lesions
Description
Change from baseline to 14 and 28 days assessed by the Investigator during the dentist examination as follows: (Yes presence of oral mucosa lesion; No = absence of oral mucosa lesion).
Time Frame
28 days
Title
Dental plaque assessment
Description
Change from T0 (at the baseline at visit, performed three hours after the last teeth brushing) to Timm (evaluation done immediately after the first product use). The evaluation is carried out by means of an erythrosine-based disclosing tablet, which allows to quantify the presence of plaque on the teeth. First, the dentist gives the tablet to the subjects, who are asked to chew it thoroughly in their mouths. Then, the subjects are asked to rub the chewed particles of the tablets on their teeth with their tongue and swish the accumulated saliva in their mouth for about 60 seconds before rinsing with water. The releasing tablet stains the plaque on the teeth.
Time Frame
1 day
Title
Teeth colour assessment
Description
Change from baseline to 14 and 28 days as assessed by the investigator during the dentist's examination comparing the subjects' teeth with those shown on the VITAPAN® Score. The scoring system consists of a series of 16 "artificial teeth" in 16 different colors, each of which is associated with an alphanumeric code representing the entire chromatic space of natural teeth. It classifies tooth color into 4 families of shades as follows: reddish-brownish (A1, A2, A3, A3.5, A4), reddish-yellowish (B1, B2, B3, B4), grayish (C1, C2, C3, C4) and reddish-grey (D2, D3, D4).
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Self-assessment questionnaire
Description
Subjects are asked to complete a self-report questionnaire on Timm (immediately after first use) and on days 14 and 28.
Time Frame
28 days
Title
Oral microbiota analysis
Description
It evaluates the change from baseline to 28 days. Oral microbiota is obtained by brushing a defined area of the mouth. Swabs are collected and stored at room temperature. Microbiome analysis is based on metagenomic analysis of the 16S rRNA gene. The second step in the analysis pipeline is to isolate the bacterial DNA from other components of the sample. Through a series of cell lysis and extraction steps, the purified bacterial material is obtained. The bacterial material is then amplified by PCR, first to increase the amount of DNA, and second to label the genetic material - which will later allow identification of each sample during the sequencing step. The concentrations of the samples are equalized prior to pooling to create the sequencing mix. This solution is then loaded into a cartridge and analyzed by a sequencer. The biodiversity index (Shannon index) and statistics are calculated using a dedicated software (Microbiome analyst)
Time Frame
28 days
Title
Serious Adverse Events/Adverse Events
Description
The number of participants with treatment-related adverse events will be assessed by CTCAE v6.0
Time Frame
14 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy Caucasian males and females aged ≥ 18 to ≤ 65 years included. Proper oral hygiene not performed verified with Simplified Oral Hygiene Index (OHI-S) (score ≥ 2) and a questionnaire on oral habit. Patients able to comply with the requirements for the study and freely willing to provide written informed consent to the collection of their data. Registered with Italian National Health Service (NHS). Ability to understand the language used in the investigation center and to comply with the study procedures. Unbanned pharmacological therapy stable for at least one month without any changes during the study. Commitment not to change the daily routine and lifestyle. Exclusion Criteria: Allergies or sensitivity to oral care products, cosmetic products, drugs, patch or medical devices. Any oral cavity condition inappropriate for participation. Gums bleeding due to pathologies/pharmacological treatment. Concomitant or during the last week antibiotic therapy. Smokers (≥5 cigarettes/day). Acute, chronic or progressive diseases/illness/conditions able to interfere with the outcome of the study or considered dangerous or incompatible with the study requirements. Pathological staining of teeth. Breast-feeding, pregnancy, or women of child-bearing age unwilling to take the necessary precautions to avoid pregnancy during the study. Planning to participate or participation in other clinical trials withing 30 days. Hospitalization/planned hospitalization in a health or social facility. Deprivation of freedom by administrative or legal decision or under guardianship Inability to be contacted in case of emergency.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dario Cattaneo, DDS
Organizational Affiliation
San Genesio ed Uniti, Pavia (Italy)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Studio D. Cattaneo
City
San Genesio ed Uniti
State/Province
Pavia
ZIP/Postal Code
27010
Country
Italy
Facility Name
Complife Italia Srl
City
San Martino Siccomario
State/Province
Pavia
ZIP/Postal Code
27028
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
32102216
Citation
Willis JR, Gabaldon T. The Human Oral Microbiome in Health and Disease: From Sequences to Ecosystems. Microorganisms. 2020 Feb 23;8(2):308. doi: 10.3390/microorganisms8020308.
Results Reference
background
PubMed Identifier
37025387
Citation
Abdulkareem AA, Al-Taweel FB, Al-Sharqi AJB, Gul SS, Sha A, Chapple ILC. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis. J Oral Microbiol. 2023 Apr 2;15(1):2197779. doi: 10.1080/20002297.2023.2197779. eCollection 2023.
Results Reference
background
PubMed Identifier
27857087
Citation
Kilian M, Chapple IL, Hannig M, Marsh PD, Meuric V, Pedersen AM, Tonetti MS, Wade WG, Zaura E. The oral microbiome - an update for oral healthcare professionals. Br Dent J. 2016 Nov 18;221(10):657-666. doi: 10.1038/sj.bdj.2016.865.
Results Reference
background
PubMed Identifier
33916013
Citation
Rajendiran M, Trivedi HM, Chen D, Gajendrareddy P, Chen L. Recent Development of Active Ingredients in Mouthwashes and Toothpastes for Periodontal Diseases. Molecules. 2021 Apr 1;26(7):2001. doi: 10.3390/molecules26072001.
Results Reference
background
Links:
URL
https://www.symrise.com/newsroom/article/symrise-launches-symrebootTM-oc-its-first-processed-probiotic-dedicated-to-oral-care/
Description
Related Info

Learn more about this trial

Open-label Trial Evaluating Four Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste, and Mouthwash

We'll reach out to this number within 24 hrs